Global News | World latest News| Trending News
Newswise — Heavy actinides — elements at the bottom of the periodic table, after plutonium — are radioactive, rare and chemically complex, making them notoriously difficult to study. Most studies conducted on these elements have traditionally been done one-compound-at-a-time or extrapolated from less toxic and non-radioactive surrogates, like lanthanides, that are safer to work with….
FOR IMMEDIATE RELEASE Newswise — A new liquid biopsy approach developed by Johns Hopkins Kimmel Cancer Center investigators could revolutionize brain cancer detection by identifying circulating DNA fragments from tumors and immune cells in blood samples, potentially enabling earlier diagnosis. A description of the work was published April 29 in Cancer Discovery. The research was partially supported…
Newswise — Professors Andy Hoffman, Cindy Schipani, and Norm Bishara join this episode of Business and Society to discuss their research and expertise on corporate governance — the systems and regulations that allow a company to operate with accountability, transparency, and fairness. Insider Trading, Employment Mobility, and Climate Change The conversation starts with a look…
Newswise — Every eight minutes, someone new is added to the national organ transplant waiting list, which has more than 103,000 people on it, the U.S. Health Resources and Services Administration reports. Just one organ donor can save as many as eight lives, and one tissue donor can help more than 100 others, according to…
Newswise — PLYMOUTH MEETING, PA [March 17, 2025] The National Comprehensive Cancer Network® (NCCN®) is sharing a webinar today that answers critical patient questions about cancer clinical trials. The newly released, on-demand webinar is titled “Why Should I Consider a Clinical Trial?” It is available for free at NCCN.org/patientwebinars thanks to funding from the NCCN…
Newswise — ROCHESTER, Minn. — A discovery by Mayo Clinic researchers may help explain why immunotherapy hasn’t been helpful for many patients with metastatic colorectal cancer. In findings published in Clinical Cancer Research, the team identified specific proteins — fibronectin and smooth muscle actin — within colorectal cancer tissues that are associated with resistance to immunotherapy treatment. Immunotherapy is…
Newswise — MARCH 11, 2025, NEW YORK – Ludwig Cancer Research congratulates Douglas Hanahan, Ludwig Distinguished Scholar at the Lausanne Branch of the Ludwig Institute for Cancer Research, on his selection as recipient of the Pezcoller Foundation-AACR International Award for Extraordinary Achievement in Cancer Research. Established 28 years ago, this highly prestigious award recognizes scientists of…
Newswise — DETROIT — A grant from the U.S. Department of Veterans Affairs (VA) will aid Wayne State University researchers in finding new insights into diabetes and its onset. Anjan Kowluru, Ph.D., distinguished professor of pharmaceutical sciences at the Eugene Applebaum College of Pharmacy and Health Sciences and senior research career scientist at the John…
Newswise — Rare Disease Day is observed on February 28 each year, or February 29th on leap years — the rarest day on the calendar. It is a day dedicated to raising awareness about rare diseases and advocating for health equity to ensure all people living with rare diseases have access to diagnosis and therapies….
Newswise — A common antihistamine may offer hope for patients with a rare genetic disease that can lead to severe liver damage and ultimately require transplantation, according to new research from Rutgers Health. The study in Cellular and Molecular Gastroenterology and Hepatology found that chlorcyclizine, a decades-old allergy medication, could potentially treat erythropoietic protoporphyria (EPP),…
